PTC Therapeutics to Participate in Upcoming Investor Conferences
PTC Therapeutics (NASDAQ: PTCT) has announced its executive team's participation in two major upcoming investor conferences in March 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
PTC Therapeutics (NASDAQ: PTCT) has announced its executive team's participation in two major upcoming investor conferences in March 2025. The company will be featured in fireside chat sessions at the TD Cowen 45th Annual Health Care Conference on March 4 at 11:10 a.m. ET and the Barclays 27th Annual Global Healthcare Conference on March 11 at 12:30 p.m. ET.
Both presentations will be accessible through live webcasts on PTC Therapeutics' investor relations website under the Events and Presentations section. The webcasts will remain archived for 30 days after the presentations. Interested parties are advised to connect to the website several minutes before the scheduled start times to ensure proper connection.
Details
News Market Reaction – PTCT
The recorded move for PTCT in the trading session of this news was -0.09%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TD Cowen 45th Annual Health Care 2025 Conference
Tuesday, March 4 at 11:10 a.m. ET
Barclays 27th Annual Global Healthcare Conference
Tuesday, March 11 at 12:30 p.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn, and X.
For More Information:
Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-in-upcoming-investor-conferences-302381204.html
SOURCE PTC Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.